![Rudolf Hanko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rudolf Hanko served as the Chief Executive Officer of Siegfried Holding AG from 2009 to 2018.
Prior to that, he was the Head of the Pharmaceutical Division at Bayer AG and the Head of the Custom Synthesis & Amino Acids Division at Evonik Industries AG.
He holds a doctorate degree from the University of Gottingen.
| Unternehmen | Position | Ende |
|---|---|---|
| EVONIK INDUSTRIES AG | Corporate Officer/Principal | - |
| BAYER AG | Corporate Officer/Principal | - |
| SIEGFRIED HOLDING AG | Vorstandsvorsitzender | 01.12.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Siegfried Holding AG
 Siegfried Holding AG Pharmaceuticals: MajorHealth Technology Develops and manufactures active pharmaceutical ingredients, dosage forms & biopharmaceutical substances | Health Technology |
University of Gottingen
 University of Gottingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evonik Industries AG
 Evonik Industries AG Chemicals: Major DiversifiedProcess Industries Operates as a holding company with interest in the manufacturing of specialty chemical products | Process Industries |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
